ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,201.54
-0.28%
Dow Jones
42,335.68
0.09%
Gold vs US Dollar
2,669.115
0.03%
Brent Oil
79.63
-0.81%
Bitcoin
96,366.16
1.97%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) News

Rezolute (RZLT)

Rezolute Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RZLT
DateTimeSourceHeadlineSymbolCompany
07/01/202513:00GlobeNewswire Inc.Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
30/12/202421:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RZLTRezolute Inc
10/12/202421:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
05/12/202413:00GlobeNewswire Inc.Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RZLTRezolute Inc
03/12/202413:00GlobeNewswire Inc.FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor HyperinsulinismNASDAQ:RZLTRezolute Inc
14/11/202423:59Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RZLTRezolute Inc
12/11/202414:35Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RZLTRezolute Inc
07/11/202421:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
07/11/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
07/11/202421:05GlobeNewswire Inc.Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
05/11/202413:00GlobeNewswire Inc.Rezolute to Participate in Upcoming Investor ConferencesNASDAQ:RZLTRezolute Inc
21/10/202420:43Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RZLTRezolute Inc
21/10/202420:41Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RZLTRezolute Inc
10/10/202420:40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RZLTRezolute Inc
24/09/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
19/09/202420:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RZLTRezolute Inc
19/09/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
19/09/202420:05GlobeNewswire Inc.Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
09/09/202411:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
09/09/202411:30GlobeNewswire Inc.FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 StudyNASDAQ:RZLTRezolute Inc
27/08/202412:00GlobeNewswire Inc.Rezolute to Participate in Upcoming Investor ConferencesNASDAQ:RZLTRezolute Inc
15/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RZLTRezolute Inc
10/08/202401:47Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RZLTRezolute Inc
05/08/202421:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RZLTRezolute Inc
05/08/202411:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
05/08/202411:30GlobeNewswire Inc.Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor HyperinsulinismNASDAQ:RZLTRezolute Inc
31/07/202412:00GlobeNewswire Inc.Rezolute to Participate in the BTIG Virtual Biotechnology ConferenceNASDAQ:RZLTRezolute Inc
27/06/202412:00GlobeNewswire Inc.Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private PlacementNASDAQ:RZLTRezolute Inc
24/06/202412:00GlobeNewswire Inc.Rezolute Announces Closing of Public Offering with Approximately $60M in Gross ProceedsNASDAQ:RZLTRezolute Inc
14/06/202420:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
 Showing the most relevant articles for your search:NASDAQ:RZLT

Your Recent History

BIT
TIP10E
Ubs BbgBarcl Tips 10 Uci...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads